Promising new drug may offer safer option for duchenne boys
NCT ID NCT05185622
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 29 times
Summary
This study tested a drug called vamorolone in 54 boys with Duchenne muscular dystrophy (DMD), a muscle-weakening disease. The goal was to see if it is safe and can help control the disease with fewer side effects than standard steroids. Boys aged 2 to under 4 and 7 to under 18 took the drug for 12 weeks, and researchers monitored their health and muscle function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Alberta's Children Hospital
Calgary, Alberta, AB T3B 6A8, Canada
-
British Columbia Children's Hospital
Vancouver, British Columbia, V6H 3N1, Canada
-
Children's Hospital of Eastern Ontario
Ottawa, Ontario, K1H 8L1, Canada
-
Montreal Childrens Hospital
Montreal, H4A 3J1, Canada
-
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
Conditions
Explore the condition pages connected to this study.